Zobrazeno 1 - 10
of 4 266
pro vyhledávání: '"PL Lin"'
Autor:
A Maiolino, M Capra, PL Lin, T Rajput, HS Friedman, C Tekle, P Bueno, E Carmo, A Freitas, F Magro
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S398-S399 (2023)
Objectives: The treatment landscape for relapsed/refractory multiple myeloma (RRMM) has witnessed a paradigm shift over the last decade, and several therapeutic options are now available in Brazil. However, approval and access to new treatments may b
Externí odkaz:
https://doaj.org/article/f4875efc4a8a4a228e8addd15870d590
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S399-S400 (2023)
Objectives: The treatment landscape for relapsed/refractory multiple myeloma (RRMM) has evolved over the last decade, and several therapeutic options are now available in Brazil. However, approval and access to new treatments may be delayed, potentia
Externí odkaz:
https://doaj.org/article/82638dc5a8eb4912ac1fd35e92dd98b2
Publikováno v:
Value in Health. 25:S385
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0df9335f735b043300bc1e3de86ef9b5
https://doi.org/10.1016/j.jval.2022.09.1911
https://doi.org/10.1016/j.jval.2022.09.1911
Publikováno v:
Value in Health. 25:S48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f35ecc8d93a7cb0d1c6923a244d42436
https://doi.org/10.1016/j.jval.2022.09.232
https://doi.org/10.1016/j.jval.2022.09.232
Publikováno v:
Value in Health. 25:S37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08b5c825fd00ced04eef20ddf8aa6914
https://doi.org/10.1016/j.jval.2021.11.173
https://doi.org/10.1016/j.jval.2021.11.173
Publikováno v:
Value in Health. 25:S267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10cb4c1f3fd97c3967bad9c3a075080d
https://doi.org/10.1016/j.jval.2021.11.1302
https://doi.org/10.1016/j.jval.2021.11.1302
Publikováno v:
Value in Health. 25:S166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e700e3099131ed45480a598e07cdfee9
https://doi.org/10.1016/j.jval.2021.11.809
https://doi.org/10.1016/j.jval.2021.11.809
Autor:
Mehta, Sahil1 (AUTHOR), Takkar, Aastha1 (AUTHOR), Singh, Deependra1 (AUTHOR), Aggarwal, Aniruddha2,3 (AUTHOR), Lal, Vivek1 (AUTHOR) vivekl44@yahoo.com
Publikováno v:
Movement Disorders Clinical Practice. Jan2022, Vol. 9 Issue 1, p113-117. 5p.
Publikováno v:
Cancer Research. 76:P4-13
Background: Liver metastasis and multiple metastatic sites are associated with higher risk of progression or death among women with hormone receptor-positive, human epidermal growth factor receptor-2-negative (HR+/HER2-) metastatic breast cancer (mBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3ae4714ec3959549bbba9ae6c32110e
https://doi.org/10.1158/1538-7445.sabcs15-p4-13-13
https://doi.org/10.1158/1538-7445.sabcs15-p4-13-13
Publikováno v:
Cancer Research. 76:P2-08
Background: Hormone receptor-positive, human epidermal growth factor receptor-2-negative (HR+/HER2-) is the most common type of metastatic breast cancer (mBC). While overall the prognosis among these patients is poor with short progression-free survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee2c21f387d5fde40865c4cbf33d431e
https://doi.org/10.1158/1538-7445.sabcs15-p2-08-20
https://doi.org/10.1158/1538-7445.sabcs15-p2-08-20